Unlocking the potential in rare disease research with decentralised trials
pharmaphorum
JANUARY 19, 2021
The report found that people’s willingness to take part in clinical trials in 2020 fell dramatically compared to previous years – however that survey was conducted with the wider public while the Raremark survey focused specifically on people with rare diseases. Research and development will always be important to rare disease patients.
Let's personalize your content